John Rogers, MD
Clinical Cardiac Electrophysiology · la Jolla, CANPI 1326003823
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 61.3% of it on its own, with 18 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,691 payments — averaging $436.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$452K
- Boston Scientific$119K
- Abbott$77K
- Kestra Medical Technology Services, Inc.$32K
- Irhythm Technologies, Inc.$26K
- Preventice Services, LLC$16K
- plus $16K from 13 others
Across 38 payments — averaging $3156.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$58K
- Abbott$50K
- Medtronic$12K
What the payments were for
- Consulting fees$280,47538%
- Speaking & faculty fees$365,81850%
- Travel & lodging$51,9607%
- Food & beverage$38,8125%
- Education$4460%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 1,352 | $452,024 |
| Boston Scientific | 89 | $118,946 |
| Abbott | 160 | $76,844 |
| Kestra Medical Technology Services, Inc. | 12 | $32,038 |
| Irhythm Technologies, Inc. | 13 | $25,828 |
| Preventice Services, LLC | 5 | $16,304 |
| Philips North America LLC | 37 | $14,626 |
| Impulse Dynamics (USA) Inc. | 4 | $501 |
| Cvrx, Inc. | 3 | $87 |
| Novartis | 4 | $81 |
| Biotronik Inc. | 4 | $74 |
| Johnson & Johnson | 1 | $24 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $22 |
| Lantheus Medical Imaging, Inc. | 1 | $21 |
| Coala Life Inc | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Pfizer | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $18 |
| Baxter Healthcare | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$43,977
- Assure WCD$31,992
- ZIO Patch$25,557
- Allure Quadra RF CRT Pacemaker$21,859
- Confirm Rx$16,016
- Micra$15,401
- BG Mini Plus$13,500
- Reveal LINQ$13,301
- Accent Pacemaker$12,900
- LINQ II$11,466
- (9520) IGT Devices Undivided$10,741
- Quadra Allure MP RF CRT Pacemkr$5,403
- Allure CRT Pacemaker$4,873
- Assurity Pacemaker$4,422
- LUX-Dx Insertable Cardiac Monitor$4,383
- WATCHMAN Access System$3,750
- Arctic Front$3,249
- Quadra Assura CRT Defibrillator$2,722
- BodyGuardian$2,500
- AURORA EV-ICD MRI SURESCAN$2,382
How this compares
$737,511 in reported general payments places this provider in the 95th percentile of 290 clinical cardiac electrophysiology providers in California.
See all clinical cardiac electrophysiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $28,941 |
| FarxigaDapagliflozin Propanediol | 17 | $14,715 |
| Rosuvastatin Calcium | 31 | $536 |
| Metoprolol Succinate | 14 | $354 |
| Potassium Chloride | 12 | $255 |
| Valsartan | 13 | $224 |
| Cephalexin | 38 | $171 |
| Losartan Potassium | 16 | $160 |
| Furosemide | 12 | $117 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $75 |
| Tramadol Hcl | 15 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $18 | $28,94125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 290 clinical cardiac electrophysiology providers in California.
Other clinical cardiac electrophysiology in la Jolla
- Nicholas Olsonla Jolla$801K
- Shephal DoshiSanta Monica$2.1M
- Jonathan HsuSan Diego$1.2M
- Leslie SaxonLos Angeles$1.1M
- Rahul BhardwajLoma Linda$935K
- Jonathan DukesVentura$775K
- Brett GidneySanta Barbara$756K
- Rajesh BankerNewport Beach$538K
- Rahul DoshiLos Angeles$469K
- Koonlawee NademaneeLos Angeles$446K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.